Ticker,Title,Link
PMVP,Buy Rating Affirmed for PMV Pharmaceuticals: Strong Financials and Promising Drug Candidate Despite Risks,8/20/2024 10:49:35 AM
PMVP,PMV Pharmaceuticals (PMVP) Gets a Buy from Craig-Hallum,8/9/2024 1:58:14 PM
PMVP,PMVP Stock Earnings: PMV Pharma Beats EPS for Q2 2024,8/8/2024 4:56:00 PM
PMVP,PMV Pharmaceuticals to Participate at Upcoming Investor Conferences in June,5/30/2024 1:00:00 PM
PMVP,"Foundation Medicine and PMV Pharma Announce Collaboration to Develop Companion Diagnostic for Rezatapopt, a First-In-Class, Investigational, Selective p53 Y220C Reactivator",5/29/2024 1:00:00 PM
PMVP,Analysts Offer Insights on Healthcare Companies: PMV Pharmaceuticals (PMVP) and Phathom Pharmaceuticals (PHAT),5/17/2024 12:50:09 PM
PMVP,Buy Rating for PMV Pharmaceuticals Amid Strong Financial Performance and Promising Drug Candidate Prospects,5/14/2024 10:30:05 AM
PMVP,PMVP Stock Earnings: PMV Pharma Beats EPS for Q1 2024,5/9/2024 5:54:19 PM
PMVP,PMV Pharmaceuticals Announces First Patient Dosed in Global Tumor-Agnostic Phase 2 PYNNACLE Trial for Rezatapopt in TP53 Y220C-Positive Solid Tumors,3/27/2024 1:00:00 PM
PMVP,Oppenheimer Remains a Hold on PMV Pharmaceuticals (PMVP),3/19/2024 11:55:09 AM
PMVP,PMV Pharmaceuticals PYNNACLE Phase I Data of Rezatapopt in Advanced Ovarian Cancer Featured in Late-Breaking Oral Presentation at 2024 SGO Annual Meeting on Women’s Cancer,3/18/2024 9:01:00 PM
PMVP,Cantor sees strong year ahead for oncology M&A,3/10/2024 5:08:00 PM
PMVP,PMV Pharmaceuticals: Buy Rating Affirmed Amid Strong Financials and Promising Clinical Prospects,3/7/2024 11:27:07 AM
PMVP,PMV Pharmaceuticals reports FY results,3/1/2024 3:35:52 PM
PMVP,TD Cowen Reaffirms Their Buy Rating on PMV Pharmaceuticals (PMVP),2/29/2024 11:35:46 PM
PMVP,PMV Pharmaceuticals to Participate in the TD Cowen 44th Annual Health Care Conference,2/26/2024 2:00:00 PM
PMVP,PMV Pharmaceuticals Announces Prioritization of PC14586 Clinical Development and Extended Cash Runway,1/18/2024 10:01:00 PM
PMVP,PMV Pharmaceuticals Strengthens Leadership with Key Appointments as Company Advances into Late-Stage Development,1/5/2024 10:01:00 PM
PMVP,"Analysts Have Conflicting Sentiments on These Healthcare Companies: Aldeyra Therapeutics (ALDX), Amylyx Pharmaceuticals Inc (AMLX) and PMV Pharmaceuticals (PMVP)",11/10/2023 12:21:13 PM
PMVP,TD Cowen Keeps Their Buy Rating on PMV Pharmaceuticals (PMVP),11/9/2023 6:54:41 PM
PMVP,PMV Pharmaceuticals Receives ‘Buy’ Rating Based on PYNNACLE Trial Results and Ongoing Cancer Research Progress,10/16/2023 10:39:00 AM
PMVP,Why Belden Shares Are Trading Lower By Over 25%? Here Are Other Stocks Moving In Friday's Mid-Day Session,10/13/2023 7:14:36 PM
PMVP,PMV Pharmaceuticals Updated PC14586 Phase 1 Data Demonstrated Anti-Tumor Activity Across Multiple Solid Tumor Types With a TP53 Y220C Mutation,10/12/2023 6:30:00 PM
PMVP,PMV Pharmaceuticals to Present Updated Phase 1 Data on PC14586 at the 2023 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics and Host a KOL Webinar,10/11/2023 6:00:00 PM
PMVP,Promising Prospects for PMV Pharmaceuticals: Buy Rating Bolstered by PC14586 Progress and Potential Accelerated Approval Pathway,10/4/2023 11:05:57 AM
PMVP,Why Flux Power Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Friday's Mid-Day Session,9/22/2023 8:22:37 PM
PMVP,PMV Pharmaceuticals to Present Updated Phase 1 Data on PC14586 at the 2023 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics,9/20/2023 10:05:00 PM
PMVP,Goldman Sachs Keeps Their Buy Rating on PMV Pharmaceuticals (PMVP),8/12/2023 9:35:31 AM
PMVP,Wall Street Analysts Are Bullish on Top Healthcare Picks,8/11/2023 10:50:09 AM
PMVP,PMV Pharmaceuticals GAAP EPS of -$0.38,8/10/2023 5:59:57 PM
PMVP,"DWAC, RCMT and PMVP are among after hour movers",8/9/2023 10:20:52 PM
PMVP,"CRSP, PDD and HA are among after hour movers",7/7/2023 9:29:48 PM
PMVP,The Latest Analyst Ratings for PMV Pharma,5/17/2023 9:02:16 PM
PMVP,H.C. Wainwright Sticks to Its Buy Rating for PMV Pharmaceuticals (PMVP),3/20/2023 10:25:26 AM
PMVP,PMV Pharmaceuticals GAAP EPS of -$1.61 beats by $0.03,3/1/2023 1:55:35 PM
PMVP,"Catalyst watch: Tesla event, Microsoft talks OpenAI, Rivian earnings and Chevron",2/24/2023 7:00:00 PM
PMVP,"BLI, SRGA and UPLD are among after hour movers",1/12/2023 11:03:23 PM
PMVP,PMV Pharmaceuticals to Participate in the 5th Annual Evercore ISI HealthCONx Conference ,11/22/2022 2:00:00 PM
PMVP,Target To Rally 29%? Plus This Analyst Predicts $245 For IQVIA Holdings,11/17/2022 1:12:09 PM
PMVP,PMV Pharmaceuticals GAAP EPS of -$0.40 beats by $0.02,11/8/2022 2:21:23 PM
PMVP,PMV Pharmaceuticals Appoints Industry Veteran Dr. Carol Gallagher to Board of Directors,11/4/2022 1:00:00 PM
PMVP,PMV Pharmaceuticals Reports Second Quarter 2022 Financial Results and Corporate Highlights,8/9/2022 2:00:00 PM
PMVP,"PMV Pharma, Merck Ink Clinical Trial Collaboration For Combination Study In Solid Tumors",7/18/2022 4:47:54 PM
PMVP,PMV Pharmaceuticals to Participate in the Goldman Sachs Global Healthcare Conference,6/8/2022 2:00:00 PM
PMVP,PMV Pharmaceuticals Initial PC14586 Phase 1 Data Presented at ASCO Demonstrated Anti-Tumor Activity Across Multiple Solid Tumor Types With a p53 Y220C Mutation,6/7/2022 6:00:00 PM
PMVP,77 Biggest Movers From Yesterday,6/1/2022 11:02:23 AM
PMVP,40 Stocks Moving In Tuesday's Mid-Day Session,5/31/2022 6:04:05 PM
PMVP,41 Stocks Moving In Friday's Mid-Day Session,5/27/2022 8:13:43 PM
PMVP,PMV Pharmaceuticals Announces Initial PC14586 Phase 1 Clinical Data to be Presented at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting,5/26/2022 11:05:00 PM
PMVP,50 Stocks Moving In Wednesday's Mid-Day Session,5/25/2022 6:10:38 PM
PMVP,PMV Pharmaceuticals Reports First Quarter 2022 Financial Results and Corporate Highlights,5/10/2022 1:30:00 PM
PMVP,92 Biggest Movers From Friday,5/9/2022 12:27:29 PM
PMVP,PMV Pharmaceuticals to Present PC14586 Phase 1 Clinical Data at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting,4/27/2022 4:30:00 PM
PMVP,Executives Sell Around $42M Of 5 Stocks,4/1/2022 3:23:34 PM
PMVP,"Benzinga's Top Ratings Upgrades, Downgrades For March 2, 2022",3/2/2022 4:32:33 PM
PMVP,PMV Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Financial Results and Corporate Highlights,3/1/2022 1:15:00 PM
PMVP,PMV Pharmaceuticals to Participate in the 42nd Annual Cowen Health Care Conference,2/28/2022 2:00:00 PM
PMVP,PMV Pharmaceuticals to Participate in the Guggenheim Healthcare Talks 2022 Oncology Day,2/3/2022 2:00:00 PM
PMVP,58 Biggest Movers From Yesterday,1/7/2022 10:29:57 AM
PMVP,PMV Pharma Announces Changes to its Board of Directors,1/6/2022 2:00:00 PM
PMVP,PMV Pharma to Present at the Evercore ISI 4th Annual HealthCONx Conference,11/22/2021 2:00:00 PM
PMVP,PMV Pharmaceuticals Reports Third Quarter 2021 Financial Results and Corporate Highlights,11/12/2021 1:15:00 PM
PMVP,"TLRY,PGEN and FGEN among after hour movers",11/5/2021 9:00:21 PM
PMVP,"Benzinga's Top Ratings Upgrades, Downgrades For September 22, 2021",9/22/2021 4:05:14 PM
PMVP,"PMV Pharmaceuticals Appoints Tim Smith as Senior Vice President, Head of Corporate Development",9/9/2021 2:00:00 PM
PMVP,PMV Pharmaceuticals to Present at the Morgan Stanley 19th Annual Global Healthcare Conference,9/2/2021 2:00:00 PM
PMVP,"The Daily Biotech Pulse: J&J Announces CEO Transition, FibroGen's Roxadustat Approved In Europe, GeoVax, Sorrento Announce COVID-19 Vaccine Data",8/20/2021 1:45:43 PM
PMVP,"Benzinga's Top Ratings Upgrades, Downgrades For August 19, 2021",8/19/2021 4:10:18 PM
PMVP,PMV Pharmaceuticals Reports Second Quarter 2021 Financial Results and Corporate Highlights,8/13/2021 2:00:00 PM
PMVP,"Benzinga's Top Ratings Upgrades, Downgrades For August 2, 2021",8/2/2021 4:23:43 PM
PMVP,"Benzinga's Top Ratings Upgrades, Downgrades For July 29, 2021",7/29/2021 4:39:52 PM
PMVP,"CRISPR, Omeros among “actionable” SMID-cap biopharma for H2 2021 at BofA",7/2/2021 6:10:10 PM
PMVP,PMV Pharmaceuticals Announces Participation at the Bank of America Securities 2021 Napa Biopharma Virtual Conference,6/9/2021 2:00:00 PM
PMVP,PMV Pharmaceuticals Announces Participation at the Goldman Sachs Annual Healthcare Conference,6/3/2021 2:00:00 PM
PMVP,PMV Pharmaceuticals Reports First Quarter 2021 Financial Results and Corporate Highlights,5/14/2021 2:00:00 PM
PMVP,"The Daily Biotech Pulse: Merck Reports Positive Keytruda Data In Breast Cancer, Curis, Evoke Slump On Earnings, Qiagen's Rapid COVID-19 Antibody Test OK'ed For Emergency Use",5/13/2021 2:10:52 PM
PMVP,"The Daily Biotech Pulse: Minerva, InflaRx Report Positive Data Readouts, Lucira COVID-19 Test Kit Available On Amazon, Decision Day For Heron",5/12/2021 2:57:17 PM
PMVP,45 Stocks Moving In Tuesday's Mid-Day Session,5/11/2021 6:01:57 PM
PMVP,PMV Pharmaceuticals Announces Participation at the Bank of America Healthcare Conference,5/5/2021 2:00:00 PM
PMVP,PMV Pharma Presents Late-Breaking Preclinical Data on Lead Product Candidate PC14586 at the American Association for Cancer Research Annual Meeting 2021,4/10/2021 7:31:00 PM
PMVP,PMV Pharma Strengthens Board of Directors with Appointment of Dr. Charles Baum,4/6/2021 2:00:00 PM
PMVP,"The Daily Biotech Pulse: Pfizer Vaccine 100% Effective In Adolescents, Equillium Readout, Amgen Goes Shopping, Achilles IPO",3/31/2021 1:41:12 PM
PMVP,"The Daily Biotech Pulse: Wave Life Sciences Pulls Plug On 2 Assets, Amarin's Vascepa Snags European Approval, Biocept Jumps On Earnings",3/30/2021 2:06:26 PM
PMVP,64 Biggest Movers From Yesterday,3/25/2021 9:59:22 AM
PMVP,PMV Pharma and Graybug Vision drop sharply as lock-up agreements expire,3/24/2021 7:40:55 PM
PMVP,Seeking Alpha Catalyst Watch,3/19/2021 7:30:46 PM
PMVP,PMV Pharmaceuticals Announces Presentation of PC14586 Preclinical Data at the American Association for Cancer Research (AACR) Annual Meeting 2021,3/10/2021 10:31:00 PM
PMVP,PMV Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results and Corporate Highlights,3/3/2021 10:01:00 PM
PMVP,PMV Pharmaceuticals Announces Participation at the Cowen 41st Annual Health Care Conference,2/23/2021 2:00:00 PM
PMVP,PMV Pharma Appoints p53 Pioneer Dr. Guillermina Lozano to Scientific Advisory Board,2/16/2021 2:00:00 PM
PMVP,"BofA's biopharma picks into 2021 set to build with new launches, 'beatable' expectations",1/5/2021 11:37:37 PM
PMVP,Stocks That Hit 52-Week Highs On Monday,1/4/2021 6:58:02 PM
PMVP,Stocks That Hit 52-Week Highs On Wednesday,12/23/2020 4:57:31 PM
PMVP,PMV Pharmaceuticals to Present at Evercore ISI 3rd Annual HealthCONx Conference,11/24/2020 11:00:00 PM
PMVP,"PMV Pharma Doses First Patient in Phase 1/2 Study of PC14586, a First-in-Class Precision Oncology Therapy That Targets Mutant p53",11/23/2020 2:00:00 PM
PMVP,PMV Pharmaceuticals Reports Third Quarter 2020 Financial Results and Corporate Highlights,11/13/2020 2:00:00 PM
PMVP,PMV Pharma Granted FDA Fast Track Designation of PC14586 for the Treatment of Advanced Cancer Patients that have Tumors with a p53 Y220C Mutation,10/13/2020 2:00:10 PM
PMVP,PMV Pharma Announces Closing of $243.5 Million Initial Public Offering  and Exercise in Full of Underwriters’ Option to Purchase Additional Shares,9/29/2020 10:05:10 PM
